# Pupil Size and Choroidal Thickness Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia Patients

> **NCT07743060** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Mohsen Pourazizi** · enrollment: 40 (estimated)

## Conditions studied

- Benign Prostatic Hyperplasia
- Silodosin
- Tamsulosin
- Choroid
- Iris Disease
- Tomography, Optical Coherence

## Interventions

- **DRUG:** tamsulosin 0.4mg
- **DRUG:** Silodosin 8 mg

## Key facts

- **NCT ID:** NCT07743060
- **Lead sponsor:** Mohsen Pourazizi
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2027-04
- **Final completion:** 2027-04
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07743060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07743060, "Pupil Size and Choroidal Thickness Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia Patients". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07743060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*